Human Genome Sciences, Inc.

Human Genome Sciences, Inc.

Human Genome Sciences, Inc.

Overview
Date Founded

1992

Headquarters

14200 Shady Grove Road,Rockville, MD 20850-7464

Type of Company

Private

Employees (Worldwide)

10K - 1M

Industries

Pharmaceuticals
Medical Support Services
Medical Products & Equipment
Hospitals & Patient Services
Biotechnology

Company Description

Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD.

Website

http://www.hgsi.com

Contact Data
Trying to get in touch with decision makers at Human Genome Sciences, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
In The News
Targeted News Service
May 12, 2020
Study Takes Most Comprehensive Look to Date at Connection Between the Ancestry and the Molecular Makeup of Cancer
Targeted News Service
May 12, 2020
International Society for Stem Cell Research Shares Recommendations for Proposed Genome Editing Registry With WHO
Business Wire
March 30, 2020
GRAIL Announces Validation of Its Multi-Cancer Early Detection Test Published in Annals of Oncology; -- CCGA Results Demonstrate Robust Validity of GRAIL's Multi-Cancer Early Detection Approach --; -- Data Support Implementation of GRAIL's Test in Clinica
Tampa Bay Times
January 15, 2020
Genetics and the idea of equality
The Canadian Press
December 11, 2019
A year after the first CRISPR babies, stricter regulations are now in place; A year after the first CRISPR babies, stricter regulations are now in place

Reveal deeper insights into your organization's relationships
with RelSci Contact Aggregator.

Empower Your Business Applications with Industry-Leading
Relationship Data from the RelSci API.

Get Contact Information on the
World's Most Influential Decision Makers.

Discover the Power of Your Network with
RelSci Premium Products.
Executives & Employees
See More
Deirdre P. Connelly

President, Chief Executive Officer & Director

Lynn Laverty Elsenhans

Chairman

Urs Rohner

Chairman

Tim Barabe

Chief Financial Officer & Senior Vice President

Tammy Shrimpton

General Manager

Matt Devalaraja

Head of Immunology Research, Pharmacokinetics & Toxicology Groups

Chester Koczynski

Director & Vice President

Richard J. Danzig

Director

Board of Directors
Joshua Ruch

Co-Founder at Rho Capital Partners, Inc.

Chester Koczynski

Director & Vice President at Human Genome Sciences, Inc.

Ian Tomlinson

Head of BioPharmaceuticals Research & Development at RadEX Co., Ltd.

Trending People
Infosys Ltd.
ONF Unveils Aether(TM) the First Open Source Platform for 5G/LTE-Edge-Cloud-as-a... - PR Newswire
Organization for Economic Cooperation and Development
Virus spread prompts Fed to slash rates in surprise move - Associated Press Financial Wire
Federal Reserve System
U.S. Federal Reserve Cuts Interest Rate by Half-Percentage Point Amid Coronaviru... - Time Magazine
The Likud Party
Israeli exit polls: Netanyahu ahead, but short of majority - Associated Press
U.S. Food and Drug Administration
Watch live: US health officials speak before Senate committee on the coronavirus... - CNBC
Trending Organizations
Infosys Ltd.
ONF Unveils Aether(TM) the First Open Source Platform for 5G/LTE-Edge-Cloud-as-a... - PR Newswire
Organization for Economic Cooperation and Development
Virus spread prompts Fed to slash rates in surprise move - Associated Press Financial Wire
Federal Reserve System
U.S. Federal Reserve Cuts Interest Rate by Half-Percentage Point Amid Coronaviru... - Time Magazine
The Likud Party
Israeli exit polls: Netanyahu ahead, but short of majority - Associated Press
U.S. Food and Drug Administration
Watch live: US health officials speak before Senate committee on the coronavirus... - CNBC
Paths to Human Genome Sciences, Inc.
Potential Connections via
Relationship Science
You
Human Genome Sciences, Inc.
Recent Transactions
Details Hidden

GlaxoSmithKline Plc purchases Human Genome Sciences, Inc.

Details Hidden

Human Genome Sciences, Inc. issued USD Common Stock

Details Hidden

Human Genome Sciences, Inc. issued USD Common Stock

Transaction Advisors
Investment Advisor
Goldman Sachs & Co. LLC

Advised onGlaxoSmithKline Plc purchases Human Genome Sciences, Inc.

Underwriter
JP Morgan Securities LLC

Advised onHuman Genome Sciences, Inc. issued USD Common Stock

Underwriter
Citigroup Global Markets, Inc. (Broker)

Advised onHuman Genome Sciences, Inc. issued USD Common Stock

Head, Biotechnology Investment Banking
Charles W. Newton

Advised onGlaxoSmithKline Plc purchases Human Genome Sciences, Inc.

Founding Partner
Daniel Katcher

Advised onGlaxoSmithKline Plc purchases Human Genome Sciences, Inc.

Partner
Jamie Moser

Advised onGlaxoSmithKline Plc purchases Human Genome Sciences, Inc.

Advisors & Consultants
Legal Advisor
Alan Klein

Partner at Simpson Thacher & Bartlett LLP

Legal Advisor
Robert W. Smith, Jr.

Partner at DLA Piper

Legal Advisor
Jennifer Bragg

Partner at Skadden, Arps, Slate, Meagher & Flom LLP
Non-Profit Donations & Grants
$50K - $100K
2013
The Leukemia & Lymphoma Society, Inc.

$5,000 - $10K
2013
Bello Machre, Inc.

$5,000 - $20K
2012
American Autoimmune Related Diseases Association, Inc.

Political Donations
$1,000
1997
Casper R. Taylor, Jr.

Investments
Details Hidden
CoGenesys, Inc.

TriGenesys, Inc. develops and commercializes biological products. It uses albumin-fusion technology to develop and commercialize certain albumin-fusion proteins for therapeutic use. The company was founded by Craig A. Rosen, Steven C. Mayer, Indra Sanyal and Mark A. Rampy in 2005 and is headquartered in Rockville, MD.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 11 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 11 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Human Genome Sciences, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Human Genome Sciences, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Human Genome Sciences, Inc..